Quality of reporting of harms in randomised controlled trials of pharmacological interventions for rheumatoid arthritis: a systematic review

Hadi, MA orcid.org/0000-0003-0108-7833, McHugh, GA orcid.org/0000-0002-5766-5885 and Conaghan, PG orcid.org/0000-0002-3478-5665 (2017) Quality of reporting of harms in randomised controlled trials of pharmacological interventions for rheumatoid arthritis: a systematic review. BMJ Evidence-Based Medicine, 22 (5). pp. 170-177. ISSN 2515-446X

Metadata

Item Type: Article
Authors/Creators:
Copyright, Publisher and Additional Information:

© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an author produced version of a paper published in Evidence-Based Medicine. Uploaded in accordance with the publisher's self-archiving policy.
Dates:
  • Accepted: 21 August 2017
  • Published (online): 2 September 2017
  • Published: 4 October 2017
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Healthcare (Leeds) > Nursing Adult (Leeds)
The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Musculoskeletal Medicine & Imaging (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 23 Aug 2017 10:10
Last Modified: 20 Apr 2021 10:55
Status: Published
Publisher: BMJ Publishing Group
Identification Number: 10.1136/ebmed-2017-110715
Open Archives Initiative ID (OAI ID):

Export

Statistics


CORE (COnnecting REpositories)